Tapewire

Nasdaq · USD

DXCM

DEXCOM INC

Export transactions ↓
Tapewire entity
3114
SEC CIK
0001093557
Parsed reports
937

Last 12 months

Inside the activity.

2 purchase rows · 30 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202523
Dec 202500
Jan 202600
Feb 202601
Mar 202601
Apr 202601
May 202603
Jun 202605
Jul 202604
Aug 202607
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 14, 2018 Filed Nov 16, 2018 22:14 UTC
Balo Andrew KEVP, Reg. Strategy, Clinical
SaleCommon Stock 800 $142.13 $113,704.00
Disclosure

SEC source: 0001093557-18-000240 · edgardoc.xml · nonDerivative · entry 2

Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,105

F1 · shares: On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $142.00 to $142.53. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
November 14, 2018 Filed Nov 16, 2018 22:14 UTC
Balo Andrew KEVP, Reg. Strategy, Clinical
SaleCommon Stock 1,200 $141.25 $169,500.96
Disclosure

SEC source: 0001093557-18-000240 · edgardoc.xml · nonDerivative · entry 1

Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,905

F1 · shares: On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $141.00 to $141.42. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
November 12, 2018 Filed Nov 15, 2018 00:29 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 11,161 $0.00 Strike: $4.58 $0.00
Disclosure

SEC source: 0001093557-18-000238 · edgardoc.xml · derivative · entry 8

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,162

Underlying: Common Stock · 11,161 shares

Expires 2019-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 12, 2018 Filed Nov 15, 2018 00:29 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
SaleCommon Stock 2,395 $148.74 $356,231.58
Disclosure

SEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 7

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,837

F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $148.32 to $149.09. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
November 12, 2018 Filed Nov 15, 2018 00:29 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
SaleCommon Stock 2,766 $147.99 $409,337.02
Disclosure

SEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 6

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,232

F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $147.28 to $148.26. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
November 12, 2018 Filed Nov 15, 2018 00:29 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
SaleCommon Stock 2,000 $146.87 $293,739.40
Disclosure

SEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 5

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,998

F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $146.22 to $147.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
November 12, 2018 Filed Nov 15, 2018 00:29 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
SaleCommon Stock 1,700 $145.55 $247,430.07
Disclosure

SEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 4

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 327,998

F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $145.19 to $146.10. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
November 12, 2018 Filed Nov 15, 2018 00:29 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
SaleCommon Stock 500 $143.00 $71,500.00
Disclosure

SEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 3

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 329,698

F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
November 12, 2018 Filed Nov 15, 2018 00:29 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
SaleCommon Stock 1,800 $142.25 $256,045.68
Disclosure

SEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 2

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 330,198

F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $142.00 to $142.71. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
November 12, 2018 Filed Nov 15, 2018 00:29 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
Exercise / conversionCommon Stock 11,161 $4.58 $51,117.38
Disclosure

SEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 1

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,998

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
November 09, 2018 Filed Nov 14, 2018 01:14 UTC
Murphy Patrick MichaelSVP, GC & Chief Compliance Off
SaleCommon Stock 400 $148.11 $59,244.00
Disclosure

SEC source: 0001093557-18-000236 · edgardoc.xml · nonDerivative · entry 1

Murphy Patrick Michael · CIK 0001692785 · SVP, GC & Chief Compliance Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,508

F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019.

Read SEC document
November 09, 2018 Filed Nov 14, 2018 01:14 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 100 $149.85 $14,985.00
Disclosure

SEC source: 0001093557-18-000235 · edgardoc.xml · nonDerivative · entry 5

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,081

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
November 09, 2018 Filed Nov 14, 2018 01:14 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 400 $149.17 $59,667.00
Disclosure

SEC source: 0001093557-18-000235 · edgardoc.xml · nonDerivative · entry 4

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,181

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $148.70 to $149.69. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
November 09, 2018 Filed Nov 14, 2018 01:14 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 1,000 $147.87 $147,871.50
Disclosure

SEC source: 0001093557-18-000235 · edgardoc.xml · nonDerivative · entry 3

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,581

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $147.56 to $148.48. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
November 09, 2018 Filed Nov 14, 2018 01:14 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 1,858 $147.18 $273,452.08
Disclosure

SEC source: 0001093557-18-000235 · edgardoc.xml · nonDerivative · entry 2

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,581

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $146.56 to $147.54. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
November 09, 2018 Filed Nov 14, 2018 01:14 UTC
ACE HEATHER SSVP Human Resources
SaleCommon Stock 900 $145.91 $131,318.01
Disclosure

SEC source: 0001093557-18-000235 · edgardoc.xml · nonDerivative · entry 1

ACE HEATHER S · CIK 0001610762 · SVP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,439

F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $145.43 to $146.23. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020.

Read SEC document
November 09, 2018 Filed Nov 14, 2018 01:13 UTC
Abbey DonaldEVP, Quality & Regulatory Afrs
SaleCommon Stock 6,900 $149.91 $1,034,361.75
Disclosure

SEC source: 0001093557-18-000234 · edgardoc.xml · nonDerivative · entry 3

Abbey Donald · CIK 0001534342 · EVP, Quality & Regulatory Afrs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,089

F1 · shares: On September 13, 2018, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $149.28 to $150.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected

F3 · balance_after: Included in this number are 70,590 restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 18,333 of which were granted on May 31, 2016 and shall vest through May 31, 2019.

Read SEC document
November 09, 2018 Filed Nov 14, 2018 01:13 UTC
Abbey DonaldEVP, Quality & Regulatory Afrs
SaleCommon Stock 1,900 $148.66 $282,459.51
Disclosure

SEC source: 0001093557-18-000234 · edgardoc.xml · nonDerivative · entry 2

Abbey Donald · CIK 0001534342 · EVP, Quality & Regulatory Afrs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,989

F1 · shares: On September 13, 2018, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $148.22 to $149.01. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected

F3 · balance_after: Included in this number are 70,590 restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 18,333 of which were granted on May 31, 2016 and shall vest through May 31, 2019.

Read SEC document
November 09, 2018 Filed Nov 14, 2018 01:13 UTC
Abbey DonaldEVP, Quality & Regulatory Afrs
SaleCommon Stock 1,750 $147.62 $258,337.98
Disclosure

SEC source: 0001093557-18-000234 · edgardoc.xml · nonDerivative · entry 1

Abbey Donald · CIK 0001534342 · EVP, Quality & Regulatory Afrs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,889

F1 · shares: On September 13, 2018, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $147.22 to $148.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected

F3 · balance_after: Included in this number are 70,590 restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 18,333 of which were granted on May 31, 2016 and shall vest through May 31, 2019.

Read SEC document
October 23, 2018 Filed Oct 26, 2018 00:59 UTC
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
SaleCommon Stock 100 $129.78 $12,978.00
Disclosure

SEC source: 0001093557-18-000223 · edgardoc.xml · nonDerivative · entry 2

DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 17,358

F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.

Read SEC document
October 23, 2018 Filed Oct 26, 2018 00:59 UTC
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
SaleCommon Stock 1,636 $128.66 $210,487.60
Disclosure

SEC source: 0001093557-18-000223 · edgardoc.xml · nonDerivative · entry 1

DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 17,458

F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $128.34 to $129.19. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.

Read SEC document
October 23, 2018 Filed Oct 26, 2018 00:58 UTC
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
SaleCommon Stock 1,100 $129.30 $142,232.53
Disclosure

SEC source: 0001093557-18-000222 · edgardoc.xml · nonDerivative · entry 2

Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,746

F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $129.06 to $129.78. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
October 23, 2018 Filed Oct 26, 2018 00:58 UTC
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
SaleCommon Stock 2,014 $128.61 $259,020.94
Disclosure

SEC source: 0001093557-18-000222 · edgardoc.xml · nonDerivative · entry 1

Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,846

F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $128.06 to $129.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
October 12, 2018 Filed Oct 16, 2018 21:27 UTC
Balo Andrew KEVP, Reg. Strategy, Clinical
SaleCommon Stock 2,009 $125.24 $251,597.72
Disclosure

SEC source: 0001093557-18-000219 · edgardoc.xml · nonDerivative · entry 2

Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,105

F1 · shares: On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $125.02 to $125.30. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
October 12, 2018 Filed Oct 16, 2018 21:27 UTC
Balo Andrew KEVP, Reg. Strategy, Clinical
SaleCommon Stock 2,991 $124.49 $372,335.83
Disclosure

SEC source: 0001093557-18-000219 · edgardoc.xml · nonDerivative · entry 1

Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,114

F1 · shares: On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $124.00 to $124.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
October 10, 2018 Filed Oct 12, 2018 20:11 UTC
Murphy Patrick MichaelSVP, GC & Chief Compliance Off
SaleCommon Stock 400 $122.20 $48,880.00
Disclosure

SEC source: 0001093557-18-000217 · edgardoc.xml · nonDerivative · entry 1

Murphy Patrick Michael · CIK 0001692785 · SVP, GC & Chief Compliance Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,908

F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019.

Read SEC document
October 08, 2018 Filed Oct 10, 2018 23:48 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 11,161 $0.00 Strike: $4.58 $0.00
Disclosure

SEC source: 0001093557-18-000215 · edgardoc.xml · derivative · entry 4

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,323

Underlying: Common Stock · 11,161 shares

Expires 2019-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 08, 2018 Filed Oct 10, 2018 23:48 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
SaleCommon Stock 4,354 $125.45 $546,201.46
Disclosure

SEC source: 0001093557-18-000215 · edgardoc.xml · nonDerivative · entry 3

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,837

F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $125.00 to $125.96. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
October 08, 2018 Filed Oct 10, 2018 23:48 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
SaleCommon Stock 6,807 $124.32 $846,231.26
Disclosure

SEC source: 0001093557-18-000215 · edgardoc.xml · nonDerivative · entry 2

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,191

F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $124.00 to $124.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
October 08, 2018 Filed Oct 10, 2018 23:48 UTC
SAYER KEVIN RDirector · President, CEO & Chairman
Exercise / conversionCommon Stock 11,161 $4.58 $51,117.38
Disclosure

SEC source: 0001093557-18-000215 · edgardoc.xml · nonDerivative · entry 1

SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,998

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:50 UTC SaleCommon Stock 100 $140.88 $14,087.50
Disclosure

SEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 7

ALTMAN STEVEN R · CIK 0001191307 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 55,355

F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:50 UTC SaleCommon Stock 100 $139.14 $13,914.00
Disclosure

SEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 6

ALTMAN STEVEN R · CIK 0001191307 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 55,455

F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:50 UTC SaleCommon Stock 300 $138.08 $41,422.50
Disclosure

SEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 5

ALTMAN STEVEN R · CIK 0001191307 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 55,555

F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $137.80 to $138.24. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:50 UTC SaleCommon Stock 650 $137.01 $89,054.49
Disclosure

SEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 4

ALTMAN STEVEN R · CIK 0001191307 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 55,855

F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $136.72 to $137.41. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:50 UTC SaleCommon Stock 300 $135.82 $40,744.50
Disclosure

SEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 3

ALTMAN STEVEN R · CIK 0001191307 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 56,505

F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $135.37 to $136.07. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:50 UTC SaleCommon Stock 700 $133.53 $93,472.47
Disclosure

SEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 2

ALTMAN STEVEN R · CIK 0001191307 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 56,805

F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $133.21 to $133.90. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.

Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:50 UTC SaleCommon Stock 350 $132.68 $46,438.49
Disclosure

SEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 1

ALTMAN STEVEN R · CIK 0001191307 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 57,505

F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $132.14 to $133.06. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.

Read SEC document
September 28, 2018 Filed Oct 1, 2018 23:10 UTC
Leach Jacob StevenChief Technology Officer
SaleCommon Stock 24,731 $144.42 $3,571,527.37
Disclosure

SEC source: 0001093557-18-000211 · edgardoc.xml · nonDerivative · entry 3

Leach Jacob Steven · CIK 0001700255 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Spouse

Disclosed balance after: 0

F1 · shares: On August 23, 2018, the reporting person's spouse adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Leach. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $144.13 to $144.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Kyndra S. Leach Trust UAD 12/12/2012, with respect to which the reporting person's spouse is a trustee.

Read SEC document
September 28, 2018 Filed Oct 1, 2018 23:10 UTC
Leach Jacob StevenChief Technology Officer
SaleCommon Stock 13,418 $143.80 $1,929,501.69
Disclosure

SEC source: 0001093557-18-000211 · edgardoc.xml · nonDerivative · entry 2

Leach Jacob Steven · CIK 0001700255 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Spouse

Disclosed balance after: 24,731

F1 · shares: On August 23, 2018, the reporting person's spouse adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Leach. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $143.13 to $144.12. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Kyndra S. Leach Trust UAD 12/12/2012, with respect to which the reporting person's spouse is a trustee.

Read SEC document
September 28, 2018 Filed Oct 1, 2018 23:10 UTC
Leach Jacob StevenChief Technology Officer
SaleCommon Stock 9,451 $142.96 $1,351,110.23
Disclosure

SEC source: 0001093557-18-000211 · edgardoc.xml · nonDerivative · entry 1

Leach Jacob Steven · CIK 0001700255 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Spouse

Disclosed balance after: 38,149

F1 · shares: On August 23, 2018, the reporting person's spouse adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Leach. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $142.12 to $143.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Kyndra S. Leach Trust UAD 12/12/2012, with respect to which the reporting person's spouse is a trustee.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:32 UTC
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
SaleCommon Stock 220 $142.49 $31,348.39
Disclosure

SEC source: 0001093557-18-000209 · edgardoc.xml · nonDerivative · entry 5

DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 19,094

F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $142.23 to $142.74. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:32 UTC
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
SaleCommon Stock 556 $141.76 $78,817.00
Disclosure

SEC source: 0001093557-18-000209 · edgardoc.xml · nonDerivative · entry 4

DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 19,314

F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $141.19 to $142.15. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:32 UTC
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
SaleCommon Stock 820 $140.84 $115,491.01
Disclosure

SEC source: 0001093557-18-000209 · edgardoc.xml · nonDerivative · entry 3

DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 19,870

F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $140.14 to $141.10. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:32 UTC
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
SaleCommon Stock 80 $139.72 $11,177.80
Disclosure

SEC source: 0001093557-18-000209 · edgardoc.xml · nonDerivative · entry 2

DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 20,690

F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $139.11 to $139.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:32 UTC
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
SaleCommon Stock 60 $138.25 $8,294.80
Disclosure

SEC source: 0001093557-18-000209 · edgardoc.xml · nonDerivative · entry 1

DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 20,770

F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $137.92 to $138.90. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:32 UTC
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
SaleCommon Stock 40 $142.77 $5,710.60
Disclosure

SEC source: 0001093557-18-000208 · edgardoc.xml · nonDerivative · entry 5

Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,860

F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $142.74 to $142.79. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:32 UTC
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
SaleCommon Stock 984 $142.17 $139,896.56
Disclosure

SEC source: 0001093557-18-000208 · edgardoc.xml · nonDerivative · entry 4

Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,900

F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $141.74 to $142.67. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:32 UTC
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
SaleCommon Stock 1,640 $141.07 $231,358.41
Disclosure

SEC source: 0001093557-18-000208 · edgardoc.xml · nonDerivative · entry 3

Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,884

F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $140.71 to $141.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:32 UTC
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
SaleCommon Stock 300 $140.24 $42,072.00
Disclosure

SEC source: 0001093557-18-000208 · edgardoc.xml · nonDerivative · entry 2

Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,524

F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $139.70 to $140.55. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:32 UTC
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
SaleCommon Stock 150 $138.69 $20,803.50
Disclosure

SEC source: 0001093557-18-000208 · edgardoc.xml · nonDerivative · entry 1

Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,824

F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $138.53 to $139.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.